Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Home - The Pharma Times | Pharma & Health Care News Portal
Tuesday, April 23, 2024

Conjunctivitis at its peak by NIIMS

New Delhi, August 17, 2023: Conjunctivitis or pink eyes or red eyes is spreading at a fast rate. It is highly infectious and might...

Apollo Hospitals announces free COVID vaccinations for children with Co-Morbidities

National, October 26, 2021: Apollo Hospitals, Asia's foremost integrated healthcare services provider, today announced free vaccinations against COVID-19 for children with specified co-morbidities across the...

Biotechnology

Hearing Loss in the Digital Age: Understanding Noise-Induced Hearing Damage and Prevention

NEW DELHI, August 24, 2023:  Our lives are constantly evolving with a steady stream of information and entertainment flowing-in through technological advancements. With various...

IT & Software Support

Wipro GE Healthcare keen to make diagnostics affordable to all

Wipro GE Healthcare is keen to invest in technologies that are affordable to all.

Terri Bresenhem, President and Chief Executive, GE Healthcare, told reporters here on Wednesday that the company has not only been expanding its presence in India for over two decades now, but investing at least 30 per cent more in recent years. “The investment is both in terms of manpower and strengthening our research and development facility,” she said.

INDIA MANUFACTURE

“We are striving to make healthcare affordable to all. While most medical equipment companies that have established their presence here import close to 80 per cent of their equipment, our import component is less. At GE Healthcare, we design and manufacture 30 per cent of the equipment in India. We have a strong research team, high quality thinkers and innovators here,” she added.

Appointments

Awards

Financial Results

Approvals

Clinical Trails

Amidst the ongoing Covid-19 pandemic ISSAR Pharma announces out-licensing of its peptide-based NCEs

ISSAR Pharma, the only company in India which focuses on research and development of New Chemical Entities (NCE), is licensing out its NCEs based...

Bulk Drug

Health Care

Alternative Medicine

Eye Care

Shortage of Donor Eyes Poses Challenges for Corneal Transplants in India: Eye Experts

Bengaluru, September 04,2023: Distinguished experts in the field of ophthalmology have raised a red flag on a pressing concern that has the potential to...

Annual Eye Screenings Vital in Low Vision Prevention: Expert

Bengaluru, February 23, 2024 : Regular annual eye screenings play a pivotal role in identifying potential vision issues before they escalate, allowing for timely...

Maxivision Super Speciality Eye Hospitals signed a Memorandum of Understanding with the Government of...

Chennai, September 13, 2023:  Maxivision Super Speciality Eye Hospitals ("Maxivision"), one of India's leading and fastest-growing chain of private eye care hospitals signed a  Memorandum of Understanding with the Government of Tamil Nadu today to set up eye hospitals across...

Product News

Media Partners

Spotlight

Investments

Packaging

Latest News

Dental Care

Hospital Management

Drug Discovery & Development

Suppliers

Technology

Companies

Innovation in Disinfectant Solutions, ‘Dry Fog C-Gate’ unveiled and the...

Hyderabad, July 07, 2020: Taking inspiration from Prime Minister Shri Narendra Modi's clarion call to 'Vocal for Local' Hyderabad's firm Ven Energy Processors Pvt...

Marketing

Our Partners

Machinery & Equipments